Eccogene

AstraZeneca says experimental obesity pill safe and tolerable in early-stage trial
MSN/Reuters
Mon, 11/4/24 - 11:25 am
AstraZeneca
obesity
clinical trials
Eccogene
AstraZeneca pays $185M upfront to reenter oral obesity gold rush, drops phase 2 sickle cell drug
Fierce Biotech
Thu, 11/9/23 - 09:58 am
AstraZeneca
obesity
sickle cell disease
Eccogene
earnings